AnaPath Services & AnaPath Research S.A.U.
Klaus Weber has extensive work experience in the field of pathology and toxicology. Klaus started their career in 1986 as an Experimental- and Toxicological Pathologist at Zentralstelle für Produktetoxikologie Pathologie. Klaus then worked as an Immunohistochemistry and Electronmicroscopy specialist at Karl-Marx-Universität Leipzig from 1986 to 1991. Klaus later served as a Visiting Medical Pathologist at Institut für Pathologie "Gustav Schmorl" in 1990. Klaus then joined RCC Research and Consulting Company Ltd. in various roles, including Head Pathology, Toxicologic Pathologist, Chief Organizational Officer, and Head of Business Unit Pharma. Klaus also worked as a Toxicologic Pathologist at K. Weber Consulting GmbH and AnaPath GmbH. Klaus was the Director of Pathology at Harlan Laboratories Ltd. and served as Chief Scientific Officer for a year. Klaus is currently the CEO and Pathologist at AnaPath GmbH.
Klaus Weber has an extensive education history in the field of Veterinary Medicine and Biology. Klaus obtained a degree equivalent to a Doctor of Veterinary Medicine (DVM) from ISV "Kurt Neubert" in 1985. Klaus then pursued higher education at Universität Leipzig "Karl Marx" and received a degree equivalent to a Master's degree in Biology in 1990. In 1989, they enrolled in Leipzig University and completed their PhD in Veterinary Medicine and Biology in 1994. Following their doctoral studies, Klaus Weber worked as a Pathologist-Guest Researcher at Experimental Pathology Laboratories Inc. in USA-Triangle Park, North Carolina starting in 1997.
This person is not in the org chart
This person is not in any offices
AnaPath Services & AnaPath Research S.A.U.
AnaPath, is a global company including contract research organization (CRO) and pathology services that provides R &D services in the preclinical and bioanalytical fields. AnaPath is formed by two main sections: AnaPath Services, based in Switzerland and focused on pathology, and AnaPath Research, based on Barcelona and focused in preclinical development. AnaPath Services emanates from RCC/Harlan and was established in 2013. It is located close to the pharmaceutical capital Basel and has a surprisingly wide experience for a young company due to company due to its history. AnaPath Services is recognized for the scientific competence in toxicologic pathology, high operational speed and reliability. The current AnaPath Research was Founded in 1980, as CIDASAL, the site had been part of multiple international companies such as RCC, Harlan and Envigo , always providing high quality services to our sponsors. In the late 2019, AnaPath services acquire the site and started a journey to the excellence of research. AnaPath is structured in departments according to the field of the services we offer, and in perfect coordination. General Toxicology performs a full range of studies to support the pharmaceutical, chemical, agrochemical and veterinary industries. The studies are performed to fulfill global regulatory guidelines in accordance with GLP (Good Laboratory Practices).